Jeffrey Crisan - 14 Jun 2021 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Director
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
14 Jun 2021
Net transactions value
-$9,948,639
Form type
4
Filing time
16 Jun 2021, 16:46:58 UTC
Previous filing
10 Jun 2021
Next filing
29 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Award +20,613,453 20,613,453 09 Jun 2021 See footnotes F1, F2, F3
transaction LFST Common Stock Sale $9,948,639 -584,870 -2.8% $17.01 20,028,583 14 Jun 2021 See footnotes F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received in the Organizational Transactions described in the prospectus dated June 9, 2021 relating to the Issuer's initial public offering, filed with the Securities and Exchange Commission on June 11, 2021, in exchange for partnership interests of LifeStance TopCo, L.P.
F2 Jeffrey Crisan is a Manager of Silversmith Partners I GP, LLC. Silversmith Partners I GP, LLC is the general partner of Silversmith Partners I GP, L.P., which is the general partner of Silversmith Capital Partners I-A, L.P., Silversmith Capital Partners I-B, L.P. and Silversmith Capital Partners I-C, L.P. (collectively, the "Silversmith Entities"). Following the transactions reported herein, Silversmith Capital Partners I-A, L.P. holds 13,780,778 of the Issuer, Silversmith Capital Partners I-B, L.P. holds 4,984,892 shares of common stock of the Issuer, and Silversmith Capital Partners I-C, L.P. holds 1,262,913 shares of common stock of the Issuer.
F3 As a result of the relationships described above, Mr. Crisan may be deemed to share voting and dispositive power with respect to the shares held by the Silversmith Entities. Mr. Crisan disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.